Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
Plus de filtres










Base de données
Gamme d'année
3.
J Pediatr Hematol Oncol ; 39(1): e27-e28, 2017 01.
Article de Anglais | MEDLINE | ID: mdl-27879542

RÉSUMÉ

The authors herein report a 5-year-old child who presented with massive hemolysis, irritability, and cyanosis. The final diagnosis was glucose-6-phosphate dehydrogenase deficiency with associated central nervous system symptoms probably because of concomitantly acquired methemoglobinemia following oxidant drug exposure. The associated acute-onset anemia would have contributed to the development of cerebral anoxia-related seizures and encephalopathy.


Sujet(s)
Déficit en glucose-6-phosphate-déshydrogénase/complications , Humeur irritable , Méthémoglobinémie/étiologie , Norfloxacine/effets indésirables , Oxydants/effets indésirables , Crises épileptiques/étiologie , Maladie aigüe , Enfant d'âge préscolaire , Consanguinité , Cyanose/étiologie , Déficit en glucose-6-phosphate-déshydrogénase/diagnostic , Déficit en glucose-6-phosphate-déshydrogénase/génétique , Humains , Mâle , Méthémoglobinémie/induit chimiquement , Méthémoglobinémie/psychologie , Méthémoglobinémie/urine , Norfloxacine/usage thérapeutique , Oxydants/usage thérapeutique , Récidive
4.
Pharmacol Biochem Behav ; 87(4): 444-52, 2007 Oct.
Article de Anglais | MEDLINE | ID: mdl-17658589

RÉSUMÉ

Cyanide is a potent toxin that binds to cytochrome oxidase blocking electron transfer and the synthesis of adenosine triphosphate (ATP). Many antidotes to cyanide poisoning oxidize hemoglobin to methemoglobin (metHb), which serves as a scavenger of the cyanide anion. However, sufficiently high levels of metHb can be toxic because metHb cannot bind O(2) until it is reduced. The purpose of the proposed study was twofold: (1) Characterize the time course of metHb formation for different doses of p-aminopropiophenone (PAPP), a drug that oxidizes hemoglobin and can be used as an antidote to cyanide intoxication; and (2) Determine whether the effort of an operant response affects the behavioral toxicity of metHb, since more effortful responses presumably are more energetically demanding. In Experiment I, the oral metHb kinetics of p-aminopropiophenone (PAPP) were studied; four doses of PAPP (1, 5, 10, and 20 mg/kg) or the vehicle, polyethylene glycol 200 (PEG200), were delivered via a gavage tube to separate groups of rats. In Experiment II, rats were trained to press a lever or run in an activity wheel at any time during a 12-hour light/dark cycle for their entire daily food intake; five presses or turns were required for the delivery of each food pellet. The same doses of PAPP were delivered p.o. shortly before the onset of darkness, 2100 h. Results from Exp I showed that PAPP induced a dose-dependent rapid increase and relatively slower exponential-like decline in metHb concentration. In Exp. II, the same doses of PAPP induced a dose-dependent reduction in hourly outputs of leverpresses and wheelturns however; wheelturns were reduced significantly more than leverpresses. When the best-fitting metHb curves from Experiment I were superimposed on the time scale for outputs of wheelturns and leverpresses, reduction of output was inversely related to the kinetics of metHb formation. These findings are consistent with the conclusion that PAPP-induced metHb formation reduced the output of wheelrunning more than leverpressing because the more energetically demanding response of wheelrunning was more affected by metHb induced hypoxemia. Furthermore, these data suggest that although certain longacting metHb formers might be useful prophylactics for warfighters, it will be critical to determine the energetic loads of required battlefield activities because even low (10%) therapeutic metHb levels might impair the performance of those activities.


Sujet(s)
Conditionnement opérant/effets des médicaments et des substances chimiques , Méthémoglobinémie/induit chimiquement , Méthémoglobinémie/psychologie , Activité motrice/effets des médicaments et des substances chimiques , Propiophénones , Algorithmes , Animaux , Aire sous la courbe , Poids/effets des médicaments et des substances chimiques , Obscurité , Interprétation statistique de données , Relation dose-effet des médicaments , Cinétique , Lumière , Mâle , Méthémoglobine/biosynthèse , Méthémoglobinémie/sang , Muscles squelettiques/effets des médicaments et des substances chimiques , Muscles squelettiques/métabolisme , Consommation d'oxygène/effets des médicaments et des substances chimiques , Rats , Rat Sprague-Dawley
5.
Biochem Biophys Res Commun ; 148(1): 384-91, 1987 Oct 14.
Article de Anglais | MEDLINE | ID: mdl-3675585

RÉSUMÉ

Effect of the deficiency of NADH-cytochrome b5 reductase on fatty acid elongation was studied in the platelets and leukocytes taken from a patient of hereditary methemoglobinemia associated with mental retardation. The activity of fatty acid elongation was determined by measuring the incorporation of [2-14C]malonyl-CoA into palmitoyl-CoA. The de novo biosynthesis of fatty acids was blocked by the addition of phosphotransacetylase, and the elongation system could be assayed in the homogenates separated from de novo biosynthesis. As compared to normal subjects approximately 40% decrease of fatty acid elongation was observed both in the platelets and leukocytes from the patient.


Sujet(s)
Acyl coenzyme A/sang , Plaquettes/métabolisme , Déficience intellectuelle/sang , Leucocytes/métabolisme , Méthémoglobinémie/sang , Palmitoyl coenzyme A/sang , Humains , Techniques in vitro , Déficience intellectuelle/étiologie , Cinétique , Malonyl coenzyme A/sang , Méthémoglobinémie/génétique , Méthémoglobinémie/psychologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...